Literature DB >> 19235662

Unique aspects of rejection and tolerance in liver transplantation.

Stuart J Knechtle1, Jean Kwun.   

Abstract

Spontaneous acceptance of liver allografts occurs in several species. However, tolerance is rare in human transplant patients even though rejection is relatively easily reversed. Histological features of acute rejection in liver transplantation are similar to those in other organs. Nevertheless, mechanisms of rejection of liver transplants may differ in degrees and cellular involvement. Liver-specific cell populations, such as Kupffer cells (KCs), liver sinusoidal epithelial cells (LSECs), and hepatic stellate cells (HSCs), may contribute to liver tolerogenicity. Other mechanisms, such as microchimerism, soluble major histocompatibility complex (MHC molecules), donor human leukocyte antigen (HLA)-C genotype, and regulatory T cells, may participate in inducing tolerance. The low incidence of hyperacute or antibody-mediated rejection in liver might be linked to the infrequency of chronic rejection of liver transplants. Understanding the mechanisms of liver transplant rejection/tolerance and the availability of better immune monitoring could help develop strategies to recognize tolerance and reduce rejection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19235662     DOI: 10.1055/s-0029-1192058

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  28 in total

1.  Molecular pathways differentiate hepatitis C virus (HCV) recurrence from acute cellular rejection in HCV liver recipients.

Authors:  Ricardo Gehrau; Daniel Maluf; Kellie Archer; Richard Stravitz; Jihee Suh; Ngoc Le; Valeria Mas
Journal:  Mol Med       Date:  2011-04-20       Impact factor: 6.354

Review 2.  Transplantation immunology: solid organ and bone marrow.

Authors:  Javier Chinen; Rebecca H Buckley
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

3.  Selective expansion of allogeneic regulatory T cells by hepatic stellate cells: role of endotoxin and implications for allograft tolerance.

Authors:  Anil Dangi; Tina L Sumpter; Shoko Kimura; Donna B Stolz; Noriko Murase; Giorgio Raimondi; Yoram Vodovotz; Chao Huang; Angus W Thomson; Chandrashekhar R Gandhi
Journal:  J Immunol       Date:  2012-03-16       Impact factor: 5.422

4.  [Effect of inhibiting TIM-4 function in Kupffer cells on liver graft rejection in mice].

Authors:  Xue-Qiang Li; Xu-Hong Li; Shi-Gang Duan; Xue-Song Xu; Yi-Ming Liu; Jin-Zheng Li; Jian-Ping Gong; Hao Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-04-20

Review 5.  Recurrence and rejection in liver transplantation for primary sclerosing cholangitis.

Authors:  Bjarte Fosby; Tom H Karlsen; Espen Melum
Journal:  World J Gastroenterol       Date:  2012-01-07       Impact factor: 5.742

6.  Identification of the rat NKG2D ligands, RAE1L and RRLT, and their role in allograft rejection.

Authors:  Ming Zhuo; Masato Fujiki; Mouer Wang; Karine Piard-Ruster; Lu-En Wai; Liang Wei; Olivia M Martinez; Sheri M Krams
Journal:  Eur J Immunol       Date:  2010-06       Impact factor: 5.532

7.  Prevention of acute liver allograft rejection by IL-10-engineered mesenchymal stem cells.

Authors:  J Niu; W Yue; Y Song; Y Zhang; X Qi; Z Wang; B Liu; H Shen; X Hu
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

Review 8.  Management of acute rejection in paediatric liver transplantation.

Authors:  D Thangarajah; M O'Meara; A Dhawan
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

Review 9.  Regulatory dendritic cells for promotion of liver transplant operational tolerance: Rationale for a clinical trial and accompanying mechanistic studies.

Authors:  Angus W Thomson; Abhinav Humar; Fadi G Lakkis; Diana M Metes
Journal:  Hum Immunol       Date:  2017-10-31       Impact factor: 2.850

10.  Old and rising stars in the lymphoid liver.

Authors:  Carlo Selmi; Mauro Podda; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.